23 related articles for article (PubMed ID: 38569830)
1. Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
Palmer TJ; Kavanagh K; Cuschieri K; Cameron R; Graham C; Wilson A; Roy K
J Natl Cancer Inst; 2024 Jun; 116(6):857-865. PubMed ID: 38247547
[TBL] [Abstract][Full Text] [Related]
2. Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3).
Madeleine MM; Johnson LG; Doody DR; Tipton ER; Carter JJ; Galloway DA
J Low Genit Tract Dis; 2016 Jul; 20(3):257-60. PubMed ID: 27224532
[TBL] [Abstract][Full Text] [Related]
3. Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women.
Coffey K; Gaitskell K; Beral V; Canfell K; Green J; Reeves G; Barnes I
Br J Cancer; 2016 Aug; 115(5):599-606. PubMed ID: 27336599
[TBL] [Abstract][Full Text] [Related]
4. The Role of Traditional Chinese Medicine in the Management of Cervical Cancer.
Wu D; Zhou R; Chen H; Pan Y; Tang Y; Zhou D
Am J Chin Med; 2024 May; ():1-13. PubMed ID: 38790084
[TBL] [Abstract][Full Text] [Related]
5. The impact of human papillomavirus vaccination on cervical cancer prevention efforts.
Massad LS; Einstein M; Myers E; Wheeler CM; Wentzensen N; Solomon D
Gynecol Oncol; 2009 Aug; 114(2):360-4. PubMed ID: 19410282
[TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study.
Lycke KD; Kahlert J; Damgaard RK; Eriksen DO; Bennetsen MH; Gravitt PE; Petersen LK; Hammer A
Am J Obstet Gynecol; 2023 Dec; 229(6):656.e1-656.e15. PubMed ID: 37595822
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
Damgaard RK; Jenkins D; Stoler MH; de Koning M; van de Sandt M; Lycke KD; Kahlert J; Gravitt PE; Quint WGV; Steiniche T; Petersen LK; Hammer A
Am J Obstet Gynecol; 2024 Jun; 230(6):655.e1-655.e10. PubMed ID: 38336125
[TBL] [Abstract][Full Text] [Related]
10. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
Shing JZ; Hu S; Herrero R; Hildesheim A; Porras C; Sampson JN; Schussler J; Schiller JT; Lowy DR; Sierra MS; Carvajal L; Kreimer AR;
Lancet Oncol; 2022 Jul; 23(7):940-949. PubMed ID: 35709811
[TBL] [Abstract][Full Text] [Related]
11. Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
Krog L; Lycke KD; Kahlert J; Randrup TH; Jensen PT; Rositch AF; Hammer A
Am J Obstet Gynecol; 2024 Apr; 230(4):430.e1-430.e11. PubMed ID: 38569830
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
